HIV preexposure prophylaxis (PrEP) is highly effective at preventing HIV acquisition, a study has confirmed. Research led by the UK Health Security Agency (UKHSA) and Chelsea and Westminster Hospital ...

Gay, bisexual, and other men who have sex with other men (MSM) during episodes of high-risk behavior could benefit from short-term use of preexposure prophylaxis (PrEP) to lessen their chances of ...

In a large clinical trial assessing Apretude, ViiV Healthcare’s recently approved injectable drug, as a form of HIV prevention, seven participants contracted the virus despite receiving their ...

Short-term investments pertaining to the distribution of PrEP are expected to result in long-term cost-savings and promote significant health benefits following its introduction in Germany, according ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

At the height of the AIDS epidemic, it seemed almost unimaginable that within 3 decades there would not only be effective treatment for the disease but also effective prophylaxis. In July 2012, in ...

A new ad campaign from the AIDS Healthcare Foundation has kicked off another round of controversy about HIV pre-exposure prophylaxis, better known as PrEP. AHF argues that the scientific evidence does ...

Please provide your email address to receive an email when new articles are posted on . More than 40 years ago, on June 5, 1981, a report of five cases of Pneumocystis pneumonia among young men in Los ...